These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33752475)

  • 41. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective functions of HNF1A variants on BCL2L1 transactivation and beta-cell growth.
    Sujjitjoon J; Charoensuk C; Thanyaphon T; Kooptiwut S; Thamtarana PJ; Tangjittipokin W; Chongjaroen N; Chanprasert C; Abubakar Z; Lapbenjakul S; Yenchitsomanus PT; Plengvidhya N
    Biochem Biophys Res Commun; 2020 Aug; 529(3):826-833. PubMed ID: 32684311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
    Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young.
    Ellard S; Thomas K; Edghill EL; Owens M; Ambye L; Cropper J; Little J; Strachan M; Stride A; Ersoy B; Eiberg H; Pedersen O; Shepherd MH; Hansen T; Harries LW; Hattersley AT
    Diabetologia; 2007 Nov; 50(11):2313-7. PubMed ID: 17828387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.
    Jeannot E; Mellottee L; Bioulac-Sage P; Balabaud C; Scoazec JY; Tran Van Nhieu J; Bacq Y; Michalak S; Buob D; ; Laurent-Puig P; Rusyn I; Zucman-Rossi J
    Diabetes; 2010 Jul; 59(7):1836-44. PubMed ID: 20393147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
    Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
    Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.
    Ley SH; Hegele RA; Connelly PW; Harris SB; Mamakeesick M; Cao H; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
    Cardiovasc Diabetol; 2010 Aug; 9():39. PubMed ID: 20716378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.
    Hoskins JW; Jia J; Flandez M; Parikh H; Xiao W; Collins I; Emmanuel MA; Ibrahim A; Powell J; Zhang L; Malats N; Bamlet WR; Petersen GM; Real FX; Amundadottir LT
    Carcinogenesis; 2014 Dec; 35(12):2670-8. PubMed ID: 25233928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
    Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
    Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
    McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
    Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway.
    Wang Z; Liu L; Du Y; Mi Y; Wang L
    Cell Biol Toxicol; 2021 Oct; 37(5):715-729. PubMed ID: 33755848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
    Thanabalasingham G; Shah N; Vaxillaire M; Hansen T; Tuomi T; Gašperíková D; Szopa M; Tjora E; James TJ; Kokko P; Loiseleur F; Andersson E; Gaget S; Isomaa B; Nowak N; Raeder H; Stanik J; Njolstad PR; Malecki MT; Klimes I; Groop L; Pedersen O; Froguel P; McCarthy MI; Gloyn AL; Owen KR
    Diabetologia; 2011 Nov; 54(11):2801-10. PubMed ID: 21814873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte nuclear factor 1 alpha (HNF1A) regulates transcription of O-GlcNAc transferase in a negative feedback mechanism.
    Zhang C; Xie F; Li L; Zhang C; Zhang Y; Ying W; Liu L; Yan X; Yin F; Zhang L
    FEBS Lett; 2019 May; 593(10):1050-1060. PubMed ID: 30953348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.
    Cheng Z; He Z; Cai Y; Zhang C; Fu G; Li H; Sun W; Liu C; Cui X; Ning B; Xiang D; Zhou T; Li X; Xie W; Wang H; Ding J
    Cell Res; 2019 Feb; 29(2):124-135. PubMed ID: 30560924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An intron mutation of HNF1A causes abnormal splicing and impairs its activity as a transcription factor.
    Wang M; Shu H; Xie J; Huang Y; Wang K; Feng R; Yu X; Guan J; Feng W; Liu M
    Mol Cell Endocrinol; 2022 Apr; 545():111575. PubMed ID: 35081418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.